A threshold effect was observed, whereby no additional benefit was observed for intakes of ⩾9 g per day.
Reduced benefit was observed for shorter treatment length and self-help administered in groups.
By contrast, no therapeutic benefit was observed in TNBS-induced colitis.
However, this benefit was observed only for neutral pictures; and it was completely absent for the emotional pictures.
To date, the initial results have been mixed: some studies showed benefit, whereas in others, no benefit was observed.
Surprisingly, no further benefit was observed after six or nine months of training, maybe due to the attention task we used (a "cue-flanker" test).
As a result of the experimentation with the use of such handy methods in the architectural design studio, a limited benefit was observed.
More recently in a clinical trial in triple-negative breast cancer, no benefit was observed for carboplatin in subjects with tumor-associated BRCA1 methylation, compared with BRCA1/2 mutation29.
However, benefit was observed in the subgroup of patients who required 10 U or more of packed red blood cells in the first 24 h.
Whilst moving them back to within the alveolus was accompanied by a variable (up to 50%), gain in bone but no soft tissue benefit was observed.
Furthermore, when simvastatin was discontinued after 2 weeks, the usual treatment duration in SAH clinical trials, rotarod performance deteriorated acutely, rCBF returned to control values, and no long-term benefit was observed in terms of visual spatial memory.
